Clivia will be chairing the Group for the next year.
Clivia will be chairing the Group for the next year. The Future and Emerging Technologies Advisory Group (FETAG) is an advisory entity set up to ensure that the European Commission receives consistent and consolidated advice during the preparation of the Horizon 2020 work programmes. Congratulations CLivia in this new responsibility!
More information available here.
ICREA Memoir 2016, now online!
Available at: icrea.cat/memoir2016
ICREA Memoir 2016, now online!
Available at: icrea.cat/memoir2016
Nuria Lopez-Bigas (ICREA at UPF) received last night the prestigious Premi Banc de Sabadell a la Investigació Biomédica for her research o
Nuria Lopez-Bigas (ICREA at UPF) received last night the prestigious Premi Banc de Sabadell a la Investigació Biomédica for her research on ellucidating the role of mutations in tumors. Nuria's research offers tools to identify the relevant mutations in a tumor, among the many thousands of irrelevant, background noise of constant mutations that take place in an evolving tumor ecosystem. An example of scientifically worthwhile and socially relevant research.
See the UPF press release here for more details.
Congratulations Núria!
Philosopher Gianni Vatimo donated his personal archives to the Universitat Pompeu Fabra in an agreement signed last Monday.
Philosopher Gianni Vatimo donated his personal archives to the Universitat Pompeu Fabra in an agreement signed last Monday. ICREA Research Professor Santi Zabala, a disciple of Vatimo, organised the event. See the video here!
Albert Marcet (ICREA Research Professor at MOVE-UAB) awarded the prestigious Jaime I award in Economy, for his outstanding contributions and impac
Albert Marcet (ICREA Research Professor at MOVE-UAB) awarded the prestigious Jaime I award in Economy, for his outstanding contributions and impact of his research. Read more about the award here.
PEPTOMYC, the spin off led by Laura Soucek (ICREA at VHIO) has just raised 1 million to complete preclinical developent of a novel tumor inhibitor,
PEPTOMYC, the spin off led by Laura Soucek (ICREA at VHIO) has just raised 1 million to complete preclinical developent of a novel tumor inhibitor, a peptyde that blocks the MYC gene, which sits in the centrer of all the signalling cascade that leads to tumor groth and proliferation. Blocking MYC has proved very successful in preclical trials: tumors seem unable to find a way around MYC, and recede very dramatically.
We wish them best of luck and we hope to see the therapy in use some time, sooner rather than later!
